Parental perceptions of barriers to blood lead testing.

J Pediatr Health Care

Ohio State University, College of Nursing, Columbus, Ohio 43210, USA.

Published: December 2005

Introduction: This study identified barriers to blood lead testing from the perspective of parents of young children eligible for Medicaid.

Method: Data were gathered from three focus groups. Participants were asked if they were familiar with the dangers of high blood lead levels, rationale for not having a child tested for blood lead, what would facilitate having blood lead testing, and how they wanted to learn about blood lead poisoning.

Results: Most parents (n=30) were unfamiliar with the causes and effects of lead poisoning. While many reported their child had been tested for lead, others were unsure because they were not told the purpose of blood draws. Participants suggested that having all services in one facility would decrease travel and thus facilitate blood lead testing; others wanted the discomfort associated with phlebotomy minimized. Participants preferred to learn about lead poisoning from low-literacy brochures, videos, and television ads.

Discussion: Nurses should institute measures in their practice sites to improve blood lead poisoning prevention education and blood lead testing rates and to reduce the pain and anxiety associated with this procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pedhc.2005.02.007DOI Listing

Publication Analysis

Top Keywords

blood lead
36
lead testing
20
lead
12
lead poisoning
12
blood
10
barriers blood
8
child tested
8
facilitate blood
8
testing wanted
8
testing
5

Similar Publications

This study was aim to investigate the effects of lipoic acid (ALA) on performance, meat quality, serum biochemistry and antioxidant function of broilers under heat stress (HS). Two hundred1-day-old Cobb broilers were randomly divided into four treatment groups and each treatment consisted of 4 replicates of 10 broilers each. The treatment group adopts a 2 × 2 two-factor setting, which is divided into two diets (basic diet or 250 mg/kg ALA diet) and two temperatures (24 ± 1℃ or 33 ± 1℃).

View Article and Find Full Text PDF

Severe bradycardia in patients with obstructive sleep apnoea and good early response to CPAP.

Sleep Breath

January 2025

Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Prądnicka 80, Kraków, 31-202, Poland.

Background: Obstructive sleep apnoea (OSA) may lead to heart rhythm abnormalities including bradycardia. Our aim was to ascertain clinical and echocardiographic parameters in patients with OSA in whom severe bradycardia was detected in an outpatient setting, as well as to evaluate the efficacy of CPAP therapy on heart rate normalization at the early stages of treatment.

Methods: Fifteen patients mild, moderate or severe OSA and concomitant bradycardia were enrolled.

View Article and Find Full Text PDF

Background: Five fulfilled hemophagocytic lymphohistiocytosis (HLH)-2004 criteria, and the HScore are widely used and recommended by international expert consensus to diagnose secondary HLH. Both diagnostic scores have never been validated in heterogeneous patient cohorts of secondary HLH patients. We aimed to systematically optimize and validate diagnostic criteria of secondary HLH using a multicenter approach.

View Article and Find Full Text PDF

Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.

Alzheimers Dement

January 2025

Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xicheng District, Beijing, China.

Alzheimer's disease (AD) is a degenerative disease characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence and progression of AD pathology has been well documented. Poor nutritional status accelerates AD progress by potentially aggravating amyloid beta (Aβ) and tau deposition, exacerbating oxidative stress response, modulating the microbiota-gut-brain axis, and disrupting blood-brain barrier function.

View Article and Find Full Text PDF

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans.

Clin Pharmacol Ther

January 2025

Department of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Clopidogrel, an anti-platelet drug, is used to prevent thrombosis after percutaneous coronary intervention. Clopidogrel resistance results in recurring ischemic events, with African Americans (AA) suffering disproportionately. The aim of this study was to discover novel biomarkers of clopidogrel resistance in African Americans using genome and transcriptome data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!